Issue : 02 DOI :
INTERNATIONAL
JOURNAL
OF
DIAGNOSTICS
AND
RESEARCH
Volume : 02
Copyright @ : - Dr.Namrata Lipne Inter. J.Digno. and Research IJDRMSID00034 |ISSN :2584-2757
19
Abstract
The Pap smear is a vital diagnostic tool in modern gynaecology, widely recognized for its role in
detecting cervical abnormalities, infections, and precancerous lesions. This test involves the collection
of cells from the cervix to identify precancerous and cancerous processes. It is a vital component in the
prevention of cervical cancer, enabling early detection and treatment of abnormal cell changes before
they progress to cancer. In Ayurveda various gynaecological disorders explained under the term Yoni
Vyapad, encompassing structural, functional, and infectious conditions caused by Dosha imbalances.
This review evaluates the diagnostic utility of Pap smear in identifying conditions that align with Yoni
Vyapad and proposes an integrated approach combining Ayurvedic principles and modern diagnostics
for comprehensive women’s healthcare.
Keywords: Pap Smear, Yoni Vyapad, Papanicolaou
Corresponding author: Dr.Namrata Lipne
Article Info: Published on : 15/01/2025
P
ISSN No. : 2584-2757
Volume : 02
Issue : 02
Publisher
ROGANIDAN VIKRUTIVIGYAN PG ASSOCIATION
FOR PATHOLOGY AND RADIODIGNOSIS
DOI
: 1 0 . 5 2 8 1 / z e n o d o . 1 4 6 5 0 0 0 2
Reg. No. : MAHA-703/16(NAG)
Year of Establishment – 2016
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH
Pap Smear as a Diagnostic Tool for Gynecological Disorders in the Context of
Yoni Vyapad: A Literature Review
Dr.Namrata Lipne
1
, Dr.Archana Kulkarni
2
,Dr.Apurva Pathak
3
1
PG Scholar , Rognidan Aum Vikruti Vigyan Department , BSDT 'S Ayurved Mahavidylaya, Wagholi, Pune.
2
Professor and Head of Rognidan Department, BSDT 'S Ayurved Mahavidylaya, Wagholi, Pune.
3
Assistant
Professor , Rognidan Department, BSDT 'S Ayurved Mahavidylaya, Wagholi, Pune.
Cite this article as: - Dr.Namrata Lipne (2025) ; Pap Smear as a Diagnostic Tool for Gynecological Disorders in the Context of
Yoni Vyapad: A Literature Review; Inter.J.Dignostics and Research 2 (2) 19-24, DOI: 1 0 . 5 2 8 1 / z e n o d o . 1 4 6 5 0 0 0 2
Introduction:
Cervical health is crucial to women’s overall well-
being. Cervical cancer remains a significant global
health challenge, ranking as the fourth most common
cancer among women. In 2020, approximately
604,000 new cases and 342,000 deaths were reported,
with the highest incidence observed in low-resource
settings due to limited screening programs
[1]
. Pap
smear, introduced by Dr. George Papanicolaou, is a
simple, cost-effective, and non-invasive diagnostic test
used to detect cervical abnormalities, infections, and
precancerous lesions
[2]
. It plays a critical role in
identifying lesions caused by human papillomavirus
(HPV), which accounts for over 90% of cervical
cancers globally
[3]
. In Ayurveda, Yoni Vyapad refers to
20 gynaecological disorders caused by Doshic
imbalances. Classical texts such as Charaka Samhita
G
A
R
V
Issue : 02
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Namrata Lipne Inter. J.Digno. and Research IJDRMSID00034 |ISSN :2584-2757
20
and Sushruta Samhita provide detailed descriptions of
these disorders, including:
1. Athisrava (Excessive Vaginal Discharge):
Correlates with bacterial vaginosis or candidiasis
[4]
2. Raktayoni (Bloody Discharge): Corresponds to
cervical dysplasia or carcinoma
[5]
3. Upapluta (Inflammation): Comparable to pelvic
inflammatory disease (PID)
[6]
While Ayurveda emphasizes holistic management,
modern diagnostics like Pap smear offer precision in
identifying cellular changes. Integrating these
approaches can enhance prevention, diagnosis, and
management.
[7]
Aim : To Study of Pap Smear as a Diagnostic Tool for
Gynecological Disorders in the Context of Yoni
Vyapad.
Objectives :
1. To correlate Yoni Vyapad conditions with modern
gynaecological disorders.
2. To assess the role of Pap smear in early detection
and prevention of gynaecological disorders.
Methodology :
This study employs a comprehensive literature review
methodology, analysing primary Ayurvedic texts
(Charaka Samhita, Sushruta Samhita ) and
contemporary clinical studies on Pap smear. Data from
peer-reviewed journals, WHO guidelines, and
PubMed-indexed articles were synthesized to explore
overlaps between Yoni Vyapad and conditions
detectable by Pap smear.
Discussion :
1.Basic Principles and Procedure:
The Pap smear involves scraping a sample of cells
from the cervix using a spatula or brush. These cells
are then examined microscopically for any
abnormalities. The cells are classified based on their
appearance, with the system developed by the
Bethesda System (TBS) being the most widely
accepted classification used today.
[8]
The following are the categories used in the Bethesda
system:
ï‚· Negative for Intraepithelial Lesion or
Malignancy (NILM): Normal cervical cells.
ï‚· Atypical Squamous Cells of Undetermined
Significance (ASC-US): Mild changes in cells
that may be indicative of an infection or a low-
grade lesion.
ï‚· Low-Grade Squamous Intraepithelial Lesion
(LSIL): Mildly abnormal changes that are
usually caused by the human papillomavirus
(HPV).
ï‚· High-Grade Squamous Intraepithelial Lesion
(HSIL): More severe changes that could
potentially lead to cervical cancer if left
untreated.
ï‚· Squamous Cell Carcinoma: Cancerous cells
that indicate invasive cervical cancer.
[9]
2.Importance of Pap Smear:
The Pap smear is essential for early detection, as
cervical cancer can develop slowly over several years.
It allows healthcare providers to monitor cellular
changes before they turn cancerous. Routine Pap
smears are recommended for women starting at age
21, and screening intervals typically range from every
3 years to every 5 years, depending on age and risk
Issue : 02
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Namrata Lipne Inter. J.Digno. and Research IJDRMSID00034 |ISSN :2584-2757
21
factors such as HPV vaccination or a history of
abnormal Pap results.
[10]
Recent studies emphasize that Pap smear testing, when
combined with HPV testing, enhances the sensitivity
of cervical cancer screening. HPV is responsible for
the majority of cervical cancers, and co-testing
provides a more accurate risk assessment than Pap
smear alone.
[11]
3.Recent Advances in Pap Smear Technology:
I. HPV Co-Testing: Research has shown that
combining the Pap smear with HPV DNA testing
(co-testing) increases the ability to detect high-
risk HPV strains, thus improving the early
detection of cervical cancer. This method is
especially beneficial for women aged 30 and
older. HPV co-testing can be done at longer
intervals than the Pap smear alone, reducing the
frequency of unnecessary tests without
compromising patient safety.
[12]
II. Liquid-Based Cytology (LBC): Liquid-based
cytology is a more advanced method of collecting
cervical cells compared to traditional Pap smears.
The process involves rinsing the spatula or brush
into a liquid preservative rather than directly
spreading the cells onto a slide. This improves the
quality of the sample, reduces the chances of
sample contamination, and allows for the
simultaneous testing of HPV. Studies suggest that
LBC provides better diagnostic accuracy than
conventional Pap smears, particularly in detecting
glandular abnormalities and HPV infections.
[13]
III. Automated Pap Smear Testing: Automated
systems are being developed to assist in analyzing
Pap smear slides. These systems use artificial
intelligence (AI) to detect abnormalities with
increased precision. While still in experimental
stages, such systems show promise in reducing
human error and improving the speed and
accuracy of diagnoses.
[14]
IV. Self-Sampling for HPV: Research is exploring the
possibility of self-collection methods for HPV
testing, where women can collect their own
samples using a swab at home. This method has
the potential to increase screening participation,
particularly among women who may have
difficulty accessing healthcare. Studies have
shown that self-sampling for HPV has
comparable accuracy to clinician-collected
samples.
[15]
4.Correlation Between some of Yoni Vyapad and
Modern Gynaecological Disorders :
Descriptions of Some Yoni Vyapad in Ayurvedic texts
align with several modern diagnoses:
1. Athisrava (Excessive Vaginal Discharge) :
• Ayurvedic Description: Caused by Kapha vitiation,
characterized by profuse, whitish, or sticky
discharge.
• Modern Correlation: Bacterial vaginosis or
candidiasis. Pap smear results reveal inflammatory
cells and microbial infections, commonly
associated with LSIL (low-grade squamous
intraepithelial lesions
.[16,17]
2. Raktayoni (Bloody Discharge) :
• Ayurvedic Description: Associated with Pitta
vitiation, leading to Dushta Raktastrava (abnormal
bleeding or spotting.)
• Modern Correlation: High-grade squamous
intraepithelial lesions (HSIL) and cervical
dysplasia. Cytological findings indicate significant
epithelial abnormalities linked to precancerous or
cancerous changes.
[18,19]
•
Issue : 02
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Namrata Lipne Inter. J.Digno. and Research IJDRMSID00034 |ISSN :2584-2757
22
3. Upapluta (Inflammation) :
• Ayurvedic Description: Pelvic inflammation
caused by vitiated Kapha and Pitta, resulting in
pain, fever, and swelling.
• Modern Correlation: Pelvic inflammatory disease
(PID) and cervicitis. Pap smears detect reactive
cellular changes and inflammation, which may
indicate chronic infections or HPV-related
conditions.
[20,21]
4. Suchimukhi (Narrow Cervical Opening) :
• Ayurvedic Description: Vata imbalance causing
constriction of the vaginal or cervical opening.
• Modern Correlation: Cervical stenosis. Abnormal
Pap smear findings often necessitate colposcopy to
further investigate cervical narrowing or
associated lesions.
[22,23]
5. Diagnostic Utility of Pap Smear :
Pap smear testing enables the early detection of:
• Infections and Inflammation: Cytological findings
reveal bacterial, fungal, and viral infections
associated with Yoni Vyapad symptoms such as
discharge and itching.
[24,25]
• Precancerous Lesions: Detecting LSIL and HSIL
ensures timely intervention to prevent invasive
cervical cancer.
[26,27]
6. Preventive and Public Health Implications :
Public health initiatives integrating Pap smear testing
with Ayurveda’s focus on lifestyle adjustments and
dietary measures provide a holistic framework for
cervical health. This approach can improve screening
uptake in underserved areas, reducing disease
burden.
[28,29]
7.Challenges and Future Directions :
Despite the success of Pap smear testing in reducing
cervical cancer rates, several challenges persist:
• Non-participation: Many women, particularly in
underserved populations, do not undergo regular
screening due to barriers such as lack of access to
healthcare, cultural stigmas, or fear of the
procedure.
• False Negatives and Positives: While Pap smears
are effective, they are not infallible. False
negatives can occur if the sample does not contain
abnormal cells or if the lab does not adequately
analyze the sample. False positives, on the other
hand, can lead to unnecessary follow-up tests and
treatments.
• Global Disparities: In low-resource settings, the
availability of trained cytopathologists and access
to laboratory facilities for Pap smears is limited,
which affects the effectiveness of cervical cancer
screening programs.
[30]
Future directions include improving the sensitivity and
specificity of HPV testing, further developing self-
sampling technologies, and expanding education and
outreach efforts to increase screening uptake globally.
Conclusion :
Pap smear is a critical diagnostic tool for the early
detection and prevention of gynaecological disorders,
particularly those described under Yoni Vyapad.
Combining modern diagnostics with Ayurvedic
principles creates a comprehensive healthcare model,
ensuring early detection, effective prevention, and
holistic treatment for women’s reproductive health.
References :
1. World Health Organization. Cervical cancer:
WHO fact sheet. Available from:
https://www.who.int/news-room/fact
sheets/detail/cervical-cancer
Issue : 02
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Namrata Lipne Inter. J.Digno. and Research IJDRMSID00034 |ISSN :2584-2757
23
2. National Cancer Institute. Pap smear: Questions
and answers. Available from:
https://www.cancer.gov/publications
3. Koutsky LA, Ault KA, Wheeler CM, et al. A
controlled trial of a human papillomavirus type
16 vaccine. N Engl J Med. 2002;347(21):1645–
51.
4. Sharma PV. Charaka Samhita, Sutrasthana,
Chapter 30, Verse 26-29. Chaukhamba
Orientalia; 1981. p. 223-226.
5. Sushruta. Sushruta Samhita, Nidanasthana,
Chapter 1, Verse 44-50. Chaukhamba Sanskrit
Series; 1994. p. 92-95.
6. Gupta A, Kaur A. The role of Ayurveda in
gynecological health: A review. Int J Ayurveda
Med. 2018;9(3):101-107.
7. Banerjee S, Khan M. Integrating traditional and
modern approaches in treating Yoni Vyapad.
Ayurveda Res. 2021;8(1):10-17.
8. Solomon D, Davey D, Kurman R. The Bethesda
System for Reporting Cervical Cytology:
Definitions, Criteria, and Explanatory Notes.
Springer Science & Business Media; 2002.
9. Wright TC Jr, Massad LS, Dunton CJ, et al.
2012 consensus guidelines for the management
of women with cervical cytological
abnormalities. J Low Genit Tract Dis.
2012;16(3):175-204
10. American Cancer Society. Cervical Cancer
Screening Guidelines. 2020. Available at:
https://www.cancer.org
11. Tota JE, Ramanakumar AV, Dias JG, et al.
HPV and cervical cancer screening in the
United States: Co-testing versus cytology alone.
Cancer. 2019;125(7):1024-1031.
12. Wentzensen N, Arbyn M, Bergeron C, et al.
Molecular testing for cervical cancer screening:
The promise and the pitfalls. J Clin Oncol.
2017;35(1):102-109.
13. Ault KA. Liquid-based cytology: What is the
evidence? J Low Genit Tract Dis.
2011;15(4):223-230.
14. Dey P, Ghosh S. Artificial intelligence and its
application in medical cytology: The next
frontier. Cytopathology. 2021;32(6):559-566.
15. Kalliala I, Rautava J, Nieminen P, et al. Self-
sampling for HPV testing: A promising new
approach. Lancet Oncol. 2020;21(10):1234-
1243.
16. Gupta R, Sharma A. Analyzing the use of Pap
smear in detecting cervical cancer in rural India.
Cancer Epidemiol. 2020;39(2):231-238.
17. Wright TC Jr, Massad LS, Dunton CJ, et al.
2012 consensus guidelines for the management
of women with cervical cytological
abnormalities. J Low Genit Tract Dis.
2012;16(3):175-204.
Issue : 02
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Namrata Lipne Inter. J.Digno. and Research IJDRMSID00034 |ISSN :2584-2757
24
18. Banerjee S, Khan M. Integrating traditional
and modern approaches in treating Yoni
Vyapad. Ayurveda Res. 2021;8(1):10-17.
19. Wentzensen N, Arbyn M, Bergeron C, et al.
Molecular testing for cervical cancer screening.
J Clin Oncol. 2017;35(1):102-109.
20. Dey P, Ghosh S. Artificial intelligence and its
application in medical cytology: The next
frontier. Cytopathology. 2021;32(6):559-566.
21. Kalliala I, Rautava J, Nieminen P, et al. Self-
sampling for HPV testing: A promising new
approach. Lancet Oncol. 2020;21(10):1234-
1243.
22. Mishra R, Singh S. Understanding the
Ayurvedic approach to cervical health and its
integration with modern gynecology. Ayurvedic
Studies. 2020;15(1):35-42.
23. Bray F, Ferlay J, Laversanne M, et al. Global
cancer statistics 2018: GLOBOCAN estimates
of incidence and mortality worldwide. CA
Cancer J Clin. 2018;68(6):394-424.
24. Nova Scotia Health Authority. Understanding
cervical changes: A health guide for women.
2019.
25. Gupta R, Sharma A. Analyzing the use of Pap
smear in detecting cervical cancer in rural India.
Cancer Epidemiol. 2020;39(2):231-238.
26. Banerjee S, Khan M. Integrating traditional
and modern approaches in treating Yoni
Vyapad. Ayurveda Res. 2021;8(1):10-17.
27. Gandhi G, Kumar R. Preventive strategies for
cervical cancer: A clinical perspective. Indian J
Cancer Res. 2020.
28. WHO. Comprehensive cervical cancer control:
A guide to essential practice. Geneva: WHO;
2014.
29. Mishra P, Sharma M. Effectiveness of Pap
smear in early cervical cancer detection: A rural
perspective. Oncology Reports.
2021;12(2):120-130.
30. Bray F, Ferlay J, Laversanne M, et al. Global
cancer statistics 2018: GLOBOCAN estimates
of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin.
2018;68(6):394-424.
ISSN: 2584-2757
DOI : 1 0 . 5 2 8 1 / z e n o d o . 1 4 6 5 0 0 0 2
Dr. Namrata Lipne Inter. J.Digno. and Research
This work is licensed under Creative
Commons Attribution 4.0 License
Submission Link : http://www.ijdrindia.com
Benefits of Publishing with us
Fast peer review process
Global archiving of the articles
Unrestricted open online access
Author retains copyright
Unique DOI for all articles
https://ijdrindia.com
